Abstract
Cutaneous viral warts are common, benign, usually self-limited papillomas with a preference for the hands and feet. A wide range of local therapies based on destruction, keratolysis, immunostimulation, or antimitotic effects have been tried for the treatment of cutaneous warts, but most of the clinical trials of these local treatments have been of low quality.1 In a review, Gibbs et al. pointed out that simple preparations containing salicylic acid are the only topical treatments for which there is good evidence of efficacy and safety.1 In this issue of the Journal, Gustafsson et al. (pages 2663–2672) report the effects of a . . .